Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

BACKGROUND: The use of circulating tumor cells (CTCs) as indicators of treatment response in metastatic colorectal cancer (mCRC) needs to be clarified. The objective of this study is to compare the Response Evaluation Criteria in Solid Tumors (RECIST) with the Cytologic Criteria Assessing Response (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Delgado-Ureña, Mayte, Ortega, Francisco G., de Miguel-Pérez, Diego, Rodriguez-Martínez, Alba, García-Puche, Jose L., Ilyine, Hugh, Lorente, Jose A., Exposito-Hernandez, Jose, Garrido-Navas, M. Carmen, Delgado-Ramirez, Miguel, Serrano, M. José
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6127986/
https://ncbi.nlm.nih.gov/pubmed/30189880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1624-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars